Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Sight Sciences, Inc. (SGHT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Investor presentation, Quarterly results
Docs: "Condensed Consolidated Balance Sheets June 30, December 31, 2023 2022 Assets Current assets: Cash and cash equivalents $ 154,515 $ 185,000 Accounts receivable, net of allowance for credit losses of $1,037 and $1,024 at June 30, 2023 and December 31, 2022, respectively 18,103 15,148 Inventory, net 7,907 6,114 Prepaid expenses and other current assets 1,795 3,415 Total current assets 182,320 209,677 Property and equipment, net 1,477 1,571 Operating lease right-of-use assets 1,125 1,614 Other noncurrent assets 367 211 Total assets $ 185,289 $ 213,073 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,947 $ 2,688 Accrued compensation 5,720 7,352 Accrued and other current liabilities 5,386 7,777 Total current liabilities 14,053 17,817 Long-term debt 33,607 33,313 Ot...",
"DELIVERING THE POWER OF SIGHT"
06/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/09/2023 8-K Regulation FD Disclosure, Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/02/2023 8-K Regulation FD Disclosure, Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/08/2023 8-K Investor presentation
Docs: "DELIVERING THE POWER OF SIGHT"
05/04/2023 8-K Quarterly results
04/03/2023 8-K Investor presentation
Docs: "Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer",
"2 3 1 2 3 TRABECULAR MESHWORK"
03/13/2023 8-K Quarterly results
Docs: "SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 185,000 $ 260,687 Accounts receivable, net 15,148 8,709 Inventory, net 6,114 3,475 Prepaid expenses and other current assets 3,415 4,164 Total current assets 209,677 277,035 Property and equipment, net 1,571 1,454 Operating lease right-of-use assets 1,614 1,495 Other noncurrent assets 211 202 Total assets $ 213,073 $ 280,186 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,688 $ 3,351 Accrued compensation 7,352 5,987 Accrued and other current liabilities 7,777 4,166 Total current liabilities 17,817 13,504 Long-term debt 33,313 32,656 Other noncurrent liabilities 1,867 1,919 Total liabilities 52,997 48,079 Commitment..."
01/09/2023 8-K Investor presentation
Docs: "Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results Company Also Announces CFO Transition",
"2 3 1 2 3 TRABECULAR MESHWORK"
11/10/2022 8-K Quarterly results
Docs: "SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 199,819 $ 260,687 Accounts receivable, net 12,593 8,709 Inventory, net 5,520 3,475 Prepaid expenses and other current assets 4,411 4,164 Total current assets 222,343 277,035 Property and equipment, net 1,568 1,454 Operating lease right-of-use assets 1,121 1,495 Other noncurrent assets 202 202 Total assets $ 225,234 $ 280,186 Liabilities, redeemable convertible preferred stock, and Stockholders’ equity Current liabilities: Accounts payable $ 3,239 $ 3,351 Accrued compensation 7,993 5,987 Accrued and other current liabilities 6,154 4,166 Total current liabilities 17,386 13,504 Long-term debt 33,158 32,656 Other noncurrent liabilities 1,751 1,919 ..."
08/23/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/10/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
04/18/2022 8-K Other Events  Interactive Data
03/24/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 260,687 $ 61,511 Accounts receivable, net 8,709 5,363 Inventory, net 3,475 2,598 Prepaid expenses and other current assets 4,164 1,161 Total current assets 277,035 70,633 Property and equipment, net 1,454 1,269 Operating lease right-of-use assets 1,495 518 Other noncurrent assets 202 386 Total assets $ 280,186 $ 72,806 Liabilities, redeemable convertible preferred stock, and stockholders’ equity Current liabilities: Accounts payable $ 3,351 $ 2,158 Accrued compensation 5,987 4,070 Accrued and other current liabilities 4,166 3,086 Total current liabilities 13,504 9,314 Long-term debt 32,656 31,955 Other noncurrent liabilities 1,919 3,055 Total li...",
"CONVENTIONAL TREATMENTS TRABECULAR BYPASS STENTS LASER TRABECULOPLASTY CONVENTIONAL SURGERY MILD"
03/16/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
03/04/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial Results MENLO PARK, Calif., January 10, 2022 — Sight Sciences, Inc. , an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients' lives, today announced preliminary unaudited financial results for the fourth quarter and year ended December 31, 2021. Preliminary and Unaudited 2021 Financial Results"
12/10/2021 8-K Quarterly results
11/12/2021 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
11/10/2021 8-K Quarterly results
Docs: "SIGHT SCIENCES, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 271,475 $ 61,511 Accounts receivable, net 8,920 5,363 Inventory, net 2,948 2,598 Prepaid expenses and other current assets 4,493 1,161 Total current assets 287,836 70,633 Property and equipment, net 1,420 1,269 Operating lease right-of-use assets 1,612 518 Other noncurrent assets 182 386 Total assets $ 291,050 $ 72,806 Liabilities, redeemable convertible preferred stock, and stockholders’ equity Current liabilities: Accounts payable $ 1,839 $ 2,158 Accrued compensation 4,639 4,070 Accrued and other current liabilities 3,837 3,086 Total current liabilities 10,315 9,314 Long-term debt 32,486 31,955 Other noncurrent liabilities 2,273 3,055 Total l..."
09/08/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
07/19/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : July 19, 2021 Sight Sciences, Inc. Delaware 001-40587 80-0625749 4040 Campbell Avenue, Suite 100 Menlo Park, CA 94025 266-1144 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the E...",
"Restated Certificate of Incorporation of Sight Sciences, Inc",
"Amended and Restated Bylaws of Sight Sciences, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy